Evaluation of Serum Biomarkers in Nutritional Disorders: Glycated Apolipoprotein B, Fasting Serum Glucose, Fructosamine, Stable and Labile Glycated Hemoglobin in Diabetic and Non-Diabetic Subjects
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 30 (4) , 925-936
Abstract
Glycated apolipoprotein B (ApoB-G), a non enzymatically glycated protein, has recently been associated with myocardial infarction. Our aim is to evaluate, in diabetic and non diabetic subjects, the relationship of ApoB-G with serum fasting glucose, fructosamine, stable and labile fractions of glycated hemoglobin ((S)HbA(1c), (L)HbA(1c), respectively) and insulin. The subjects were recruited from a previous study on ApoB-G and myocardial infarction: 141 of them were studied, 43 with and 98 without diabetes. ApoB-G was measured using a monoclonal antibody, and linear regression and correlation were used for statistical analysis of the data. ApoB-G was higher in diabetic than in non diabetic subjects. There was a statistically significant correlation of ApoB-G with triglycerides (r = 0.38, p = 0.01) in diabetic subjects, and with total proteins (r = 0.37, p = 0.0002), triglycerides (r = 0.34, p = 0.0007), and cholesterol (r = 0.23, p = 0.02) in non diabetic subjects. In the most parsimonious multiple linear regression model of ApoB-G on all the other serum variables, there was a statistically significant association of ApoB-G with triglycerides, in both diabetic and non diabetic subjects. The main results of this study suggest that serum ApoB-G is associated with serum triglycerides in both diabetic and non diabetic subjects.Keywords
This publication has 37 references indexed in Scilit:
- Glycated apolipoprotein B and myocardial infarctionNutrition, Metabolism and Cardiovascular Diseases, 2007
- Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain.Journal of Epidemiology and Community Health, 1994
- Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Impaired hepatocyte binding, uptake and degradation of glucosylated low-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Measurement of Receptor-Independent Metabolism of Low-Density Lipoprotein. An Application of Glycosylated Low-Density LipoproteinEuropean Journal of Biochemistry, 1983
- Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylationMetabolism, 1982
- Methodological problems in characterizing an individual's plasma glucose levelJournal of Chronic Diseases, 1982
- Non‐enzymatic glycosylation of human serum lipoproteins Elevated ϵ‐lysine glycosylated low density lipoprotein in diabetic patientsFEBS Letters, 1981
- FAST GLYCOSYLATION OF HÆMOGLOBINThe Lancet, 1979
- The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo.Journal of Clinical Investigation, 1976